The rationale for targeting the JAK/STAT  pathway in scleroderma-associated interstitial lung disease

Immunotherapy, Ahead of Print.

Source: Immunotherapy - December 2, 2020 Category: Allergy & Immunology Authors: Rossella Talotta Source Type: research